Artemis Investment Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$59M Buy
94,503
+56,830
+151% +$33.3M 0.51% 77
2026
Q2
$20M Buy
37,673
+13,663
+57% +$6.31M 0.18% 129
2026
Q1
$11.5M Buy
+24,010
New +$12.3M 0.12% 135
2024
Q3
– Sell
-53,897
Closed -$22.2M – 217
2024
Q2
$22.2M Buy
+53,897
New +$21.3M 0.3% 93
2023
Q1
– Sell
-20,838
Closed -$4.45M – 235
2022
Q4
$4.45M Buy
+20,838
New +$4.16M 0.05% 176

Other funds holding MEDP

Artemis Investment Management's MEDP Position: Q3 2026 in Review

Artemis Investment Management increased its Medpace (MEDP) stake by 151% in Q3 2026, buying an estimated $33.3M and bringing the position to 94,503 shares worth $59M. The position accounts for 0.51% of the portfolio, ranked #77.

Artemis Investment Management first reported a position in MEDP in Q4 2022 and has held it in 5 quarters since. 22 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Artemis Investment Management held 94,503 shares of Medpace worth $59M as of Q3 2026.
  • Artemis Investment Management bought 56,830 Medpace shares in Q3 2026, an estimated $33.3M.
  • Medpace made up 0.51% of Artemis Investment Management's portfolio in Q3 2026, its #77 holding.
  • Artemis Investment Management first reported a position in Medpace in Q4 2022 and has held it in 5 quarters since.
  • 22 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Artemis Investment Management's 13F filing for Q3 2026, filed 8 Oct 2026.